JP Morgan Maintains Neutral on Doximity, Lowers Price Target to $28

Doximity, Inc. Class A

Doximity, Inc. Class A

DOCS

0.00

JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE: DOCS) with a Neutral and lowers the price target from $33 to $28.